Jawbone showdown: which graft technique wins?
NCT ID NCT07210385
First seen Oct 31, 2025
Summary
This study tests two methods for rebuilding the upper jaw where bone is too thin for dental implants. One method uses a sticky mix of the patient's own bone and cow bone; the other uses a bone shell technique. Thirty adults will be randomly assigned to one method, and after 6 months, doctors will measure how much new bone formed and how healthy it is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAXILLARY AUGMENTATION IN HORIZONTAL BONE DEFECT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cairo University
Al Manyal, Giza Governorate, 12613, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bone graft (autogenous bone chips mixed with bovine bone)
What this could lead to
If successful, this could identify a better technique for rebuilding jawbone, making dental implants possible for more people.
What could go wrong
This is a small, early-stage trial with only 30 participants. Results may not apply to everyone, and both techniques carry risks like infection or graft failure.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.